公开(公告)号：US12059543B2

公开(公告)日：2024-08-13

申请号：US16640210

申请日：2018-08-24

Applicant: Roivios Limited

Inventor： David E. Orr ,  Jacob L. Upperco ,  John R. Erbey, II

IPC: A61M27/00

CPC classification number: A61M27/008 ,  A61M2027/004 ,  A61M2205/3334 ,  A61M2205/3337 ,  A61M2205/3507 ,  A61M2205/3553 ,  A61M2205/8206 ,  A61M2205/8243 ,  A61M2210/1082 ,  A61M2210/1085 ,  A61M2210/1089

Abstract: A pump assembly is provided, including a pump module configured to be positioned within an interior portion of a ureter and/or renal pelvis of a patient for providing negative pressure to the patient's ureter and/or kidney, the pump module including: a housing including a flow channel for conducting fluid, wherein the housing is configured to be positioned within the interior portion of the ureter and/the renal pelvis; and a pump element positioned within the channel to draw fluid through the channel; and a control module coupled to the pump module, the control module being configured to direct motion of the pump element to control flow rate of fluid passing through the channel, and including a housing configured to be positioned within at least one of a second interior portion of the patient's ureter, a second portion of the patient's renal pelvis, or an interior portion of a patient's bladder.

公开(公告)号：US20230404421A1

公开(公告)日：2023-12-21

申请号：US18460185

申请日：2023-09-01

Applicant: TC1 LLC

Inventor： Daniel I. Harjes ,  Kathryn B. Frederick ,  Eric Lee

IPC: A61B5/029 ,  A61B5/00 ,  A61M60/148 ,  A61M60/88 ,  A61M60/546 ,  A61M60/422 ,  A61M60/237 ,  A61M60/178 ,  A61M60/221 ,  A61M60/232 ,  A61M60/531

CPC classification number: A61B5/029 ,  A61B5/02405 ,  A61M60/148 ,  A61M60/88 ,  A61M60/546 ,  A61M60/422 ,  A61M60/237 ,  A61M60/178 ,  A61M60/221 ,  A61M60/232 ,  A61M60/531 ,  A61M2210/125 ,  A61M2205/3334 ,  A61M2205/3507 ,  A61B5/0031

Abstract: The invention generally relates to heart pump systems. In some embodiments, a pressure sensor is provided with a heart pump, either at the inflow or the outflow of the blood pump. The heart pump may further include a flow estimator based on a rotor drive current signal delivered to the rotor. Based on the rotor drive current signal, a differential pressure across the pump may be calculated. The differential pressure in combination with the pressure measurements from the pressure sensor may be used to calculate pressure on the opposite side of the pump from the pressure sensor. In some embodiments, the pressure sensor is located at the outflow of the pump and the pump is coupled with the left ventricle. The differential pressure and pressure measurement may be used to calculate a left ventricular pressure waveform of the patient. With such a measurement, other physiological parameters may be derived.

公开(公告)号：US20230390543A1

公开(公告)日：2023-12-07

申请号：US18235254

申请日：2023-08-17

Applicant: Veris Health, Inc.

Inventor： James D. Mitchell ,  Andrew A. Thoreson ,  Theodore C. Johnson

IPC: A61M39/02 ,  G16H20/17 ,  G16H40/67 ,  G16H10/60

CPC classification number: A61M39/0208 ,  G16H20/17 ,  G16H40/67 ,  G16H10/60 ,  A61M2039/0223 ,  A61M2205/04 ,  A61M2205/3368 ,  A61M2205/3507 ,  A61M2205/52 ,  A61M2205/587 ,  A61M2205/6054 ,  A61M2205/8206 ,  A61M2230/06 ,  A61M2230/42 ,  A61M2230/63

Abstract: Implantable ports used for intravenous administration and methods of using the same.

公开(公告)号：US11672445B2

公开(公告)日：2023-06-13

申请号：US16253649

申请日：2019-01-22

Applicant: EyeSense GmbH

Inventor： Achim Muller ,  Tom Meissner-Braun ,  Matthias Pischan

IPC: A61B5/145 ,  A61B17/34 ,  A61B5/00 ,  A61B90/00

CPC classification number: A61B5/14503 ,  A61B5/14532 ,  A61B5/6848 ,  A61B17/3421 ,  A61B17/3468 ,  A61B5/0031 ,  A61B5/14507 ,  A61B5/14546 ,  A61B5/683 ,  A61B2017/3409 ,  A61B2090/034 ,  A61B2090/035 ,  A61B2560/045 ,  A61B2560/0425 ,  A61B2560/063 ,  A61B2560/066 ,  A61M2205/3507 ,  A61M2230/201

Abstract: An injector for transcutaneously introducing a sensor into a patient, including a cannula, a base element, a sliding element arranged displaceably on the base element, for transcutaneously introducing the cannula into the patient in an injection direction, and including an ejection element for automatically pulling the cannula out of the patient counter to the injection direction by the ejection element in an ejection operation. The injector has a locking element for the ejection element such that, in a delivery state, the ejection element is lockable in an energy-charged state, and the sliding element and the locking element are configured to interact indirectly or directly in order, in an injection state, when the cannula is introduced transcutaneously into the patient, to release the locking of the ejection element in order automatically to start the ejection operation.

公开(公告)号：US20190232029A1

公开(公告)日：2019-08-01

申请号：US16378376

申请日：2019-04-08

Applicant: Sequana Medical AG

Inventor： Thomas Werner DEGEN ,  Daniel Thomas THOMMEN ,  Noel L. JOHNSON

IPC: A61M27/00 ,  A61M5/142 ,  A61M1/28

CPC classification number: A61M27/002 ,  A61M1/28 ,  A61M5/14236 ,  A61M5/14276 ,  A61M2205/10 ,  A61M2205/3368 ,  A61M2205/3379 ,  A61M2205/3507 ,  A61M2205/3569 ,  A61M2205/502 ,  A61M2205/52 ,  A61M2205/8243 ,  A61M2230/005 ,  A61M2230/42 ,  G06F19/3468 ,  G16H20/17

Abstract: A fluid management system for the treatment of ascites, pleural effusion or pericardial effusion is provided including an implantable device including a pump, control circuitry, battery and transceiver; a charging and communication system configured to periodically charge the battery and communicate with the implantable device to retrieve performance data; and monitoring and control software, suitable for use with conventional personal computers, for configuring and controlling operation of the implantable device and charging and communication system. The implantable device includes a number of features that provide automated movement of fluid to the bladder with reduced risk of clogging, with no patient involvement other than occasional recharging of the battery of the implantable device. The monitoring and control software is available only to the treating physician, such that the physician interacts with the implantable device via the charging and communication system.

公开(公告)号：US20180207354A1

公开(公告)日：2018-07-26

申请号：US15924362

申请日：2018-03-19

Applicant: Peter Forsell

Inventor： Peter Forsell

IPC: A61M5/142 ,  A61M5/14 ,  A61F2/26 ,  A61M5/158 ,  A61M5/172 ,  A61M5/44 ,  A61M39/02

CPC classification number: A61M5/14276 ,  A61F2/26 ,  A61M5/1407 ,  A61M5/1408 ,  A61M5/14212 ,  A61M5/14236 ,  A61M5/1428 ,  A61M5/158 ,  A61M5/1723 ,  A61M5/44 ,  A61M39/0208 ,  A61M2005/14208 ,  A61M2005/14284 ,  A61M2205/33 ,  A61M2205/3303 ,  A61M2205/3507 ,  A61M2205/3523 ,  A61M2205/353 ,  A61M2205/3606 ,  A61M2205/3613 ,  A61M2205/364 ,  A61M2205/366 ,  A61M2205/3673 ,  A61M2205/502 ,  A61M2205/82 ,  A61M2205/8243 ,  A61M2209/045 ,  A61M2210/167

Abstract: An at least partly implantable system for injecting a substance into a patient's body, in particular a penis erection stimulation system, comprises one or more long, flexibly bendable infusion needles, the tip ends of which are disposed within and implanted along with at least one first housing, in particular adjacent the patient's left and right corpora cavernosa. The respective other end or ends of the infusion needles are disposed and implanted along with at least one second housing remote from the first housing. A reservoir and a pump are also implanted inside the patient's body to supply the infusion needle with infusion liquid. A drive unit also adapted for implantation inside the patient's body is arranged for advancing and retracting the infusion needle such that its tip end penetrates the at least one first housing's outer wall in at least one penetration area, more specifically at least in two different penetration areas either simultaneously or in immediate time succession, thereby injecting the substance into the patient's body.

公开(公告)号：US20180050154A1

公开(公告)日：2018-02-22

申请号：US15239262

申请日：2016-08-17

Applicant: INTERNATIONAL BUSINESS MACHINES CORPORATION

Inventor： Amos Cahan

IPC: A61M5/172 ,  A61M5/142 ,  A61M5/42

CPC classification number: A61M5/1723 ,  A61M5/142 ,  A61M5/14276 ,  A61M2202/07 ,  A61M2205/04 ,  A61M2205/3507 ,  A61M2205/3584 ,  A61M2205/50 ,  A61M2205/502 ,  A61M2205/52 ,  A61M2205/581 ,  A61M2205/8206 ,  A61M2210/12 ,  A61M2230/005 ,  A61M2230/20 ,  A61M2230/201

Abstract: Embodiments include methods and systems for maintaining glucose homeostasis. Systems can include a pump, a first reservoir including a homeostasis agent, an umbilical catheter capable of being advanced in the umbilical vein or in the falciform ligament, and a sensor. Systems can also include a biocompatible coating, a microprocessor in communication with the pump and the sensor, and a power supply. Methods can include implanting a pump and reservoir subcutaneously in a patient, advancing a catheter in the umbilical vein or in the falciform ligament, measuring a blood glucose level, pumping a homeostasis agent, and administering the homeostasis agent to the portal venous system.

公开(公告)号：US20180008760A1

公开(公告)日：2018-01-11

申请号：US15713066

申请日：2017-09-22

Applicant: Leviticus Cardio Ltd.

Inventor： Michael Zilbershlag ,  Neri Naveh ,  Roni Daffan

IPC: A61M1/12 ,  H01M2/02 ,  A61N1/378 ,  H01M2/06

CPC classification number: A61M1/127 ,  A61M1/122 ,  A61M2205/3507 ,  A61M2205/8206 ,  A61N1/378 ,  H01M2/0207 ,  H01M2/06 ,  H01M2/34 ,  H01M10/052 ,  H01M10/4207 ,  H01M10/4257 ,  H01M10/441 ,  H01M10/482 ,  H01M10/488 ,  H01M2010/4271 ,  H01M2200/00 ,  H02J7/0026 ,  Y02T10/7055 ,  Y10T307/625

Abstract: Multi-cell battery packs can be made safer with certain features that mitigate the consequences of cell failure. Parameters of a cell are monitored to determine when the cell should be disconnected from the pack in case of a fault. The battery is reconfigured to continue operating in a safer mode. An over-charging prevention system reduces the maximum voltage that remaining battery pack can be charged to, so that the cells do not overcharge. Additional circuitry allows the disconnected cell to be periodically reconnected to the battery pack to determine if its conditions have sufficiently improved. The cells also include components for self-powering these cell functions while it is disconnected from the rest of the circuit.

公开(公告)号：US09709061B2

公开(公告)日：2017-07-18

申请号：US15172760

申请日：2016-06-03

Applicant: TC1 LLC

Inventor： Masamichi Yanai ,  Jeffrey H. Campau ,  Jason C. Nanna

IPC: F04D15/00 ,  A61M1/10 ,  F04D7/04 ,  F04B35/04 ,  H02P6/18 ,  A61M1/12 ,  F04D13/02 ,  F04D29/047 ,  F04D29/048 ,  F04D29/42 ,  F04D13/06 ,  F04D29/041 ,  F04D29/22

CPC classification number: F04D15/0094 ,  A61M1/101 ,  A61M1/1012 ,  A61M1/1015 ,  A61M1/1017 ,  A61M1/1031 ,  A61M1/1036 ,  A61M1/1086 ,  A61M1/122 ,  A61M2205/3303 ,  A61M2205/3507 ,  F04B35/04 ,  F04D7/04 ,  F04D13/024 ,  F04D13/0666 ,  F04D15/0088 ,  F04D29/041 ,  F04D29/0473 ,  F04D29/048 ,  F04D29/22 ,  F04D29/426 ,  F04D29/428 ,  H02P6/18

Abstract: A centrifugal pump system having an impeller rotating with first and second magnetic structures on opposite surfaces. A levitation magnetic structure is disposed at a first end of a pump housing having a levitating magnetic field for axially attracting the first magnetic structure. A multiphase magnetic stator at a second end of the pump housing generates a rotating magnetic field for axially and rotationally attracting the second magnetic structure. A commutator circuit provides a plurality of phase voltages to the stator. A sensing circuit determines respective phase currents. A controller calculates successive commanded values for the phase voltages in response to the determined phase currents and a variable commutation angle. The angle is selected to correspond to an axial attractive force of the stator that maintains a levitation of the impeller at a centered position within the pumping chamber.

公开(公告)号：US09415163B2

公开(公告)日：2016-08-16

申请号：US13809580

申请日：2010-07-20

Applicant: Leonardo Ricotti ,  Tareq Assaf ,  Cesare Stefanini ,  Arianna Menciassi

Inventor： Leonardo Ricotti ,  Tareq Assaf ,  Cesare Stefanini ,  Arianna Menciassi

IPC: A61M5/172 ,  A61M5/142 ,  A61M39/04

CPC classification number: A61M5/1723 ,  A61M5/14276 ,  A61M39/04 ,  A61M2205/3507 ,  A61M2205/502 ,  A61M2205/8206 ,  A61M2209/045 ,  A61M2209/086

Abstract: A system for the controlled administration of a substance by means of an infusion device implanted in the human body is described. The system has an implantable unit for detecting a shortage or an excess of such substance or a physiological parameter correlatable to the shortage or excess of such substance, an infusion group of this substance implantable in the peritoneal cavity and having a central control unit for processing data received from the detection unit, and energy storage means to power such infusion group. The system also has a carrier of such substance adapted to be ingested, and a refilling device for refilling the infusion group with such substance.

Abstract translation: 描述了通过植入人体内的输注装置对物质进行受控管理的系统。 该系统具有用于检测这种物质的短缺或过量的植入式单元或与该物质的短缺或过量相关的生理参数，该物质的输注组可植入腹膜腔并具有用于处理数据的中央控制单元 从所述检测单元接收到的能量存储装置，为所述输注组提供动力。 该系统还具有适于摄取的这种物质的载体，以及用该物质重新灌注输液组的再填充装置。